Skip Content

16 May 2018

Polyphor gets in pole position for IPO

Polyphor, which has collaboration agreements in place with multiple pharmaceutical companies, raised $155m when it floated on the SIX Swiss Exchange.

Author: Thierry Heles, Reporter

Polyphor, a Switzerland-based biopharmaceutical company backed by multiple healthcare corporates, listed on the SIX Swiss Exchange yesterday after pricing its shares at CHF38 ($38) each.